Isoflurane preconditioning ameliorates renal ischemia-reperfusion injury through antiinflammatory and antiapoptotic actions in rats

Biological and Pharmaceutical Bulletin

Volumn 37, Issue 10, 2014, Pages 1599-1605

  Liang, Yaoxian ^a   Li, Zhengqian ^a   Mo, Na ^b   Li, Min ^a   Zhuang, Zhen ^a   Wang, Jun ^a   Wang, Yue ^a   Guo, Xiangyang ^a  

^a PEKING UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

Author keywords

Acute kidney injury; Apoptosis; Infammation; Ischemia reperfusion; Volatile anesthetic

Indexed keywords

CASPASE 3; CREATININE; HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; ISOFLURANE; PROTEIN BAX; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL INFILTRATION; CELL SWELLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DRUG EFFECT; KIDNEY INTERSTITIUM; KIDNEY ISCHEMIA; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE EPITHELIUM; MALE; NEPHRITIS; NONHUMAN; PREMEDICATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RENAL PROTECTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; ANIMAL; BLOOD; DRUG EFFECTS; ISCHEMIC PRECONDITIONING; KIDNEY; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; ISCHEMIC PRECONDITIONING; ISOFLURANE; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84908028104     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b14-00211     Document Type: Article

References (32)

1. Gueler F, Gwinner W, Schwarz A, Haller H. Long-term effects of acute ischemia and reperfusion injury. Kidney Int., 66, 523-527 (2004).
2. Rabadi MM, Ghaly T, Goligorksy MS, Ratliff BB. HMGB1 in renal ischemic injury. Am. J. Physiol. Renal Physiol., 303, F873-F885 (2012).
3. Yang JR, Yao FH, Zhang JG, Ji ZY, Li KL, Zhan J, Tong YN, Lin LR, He YN. Ischemia-reperfusion induces renal tubule pyroptosis via the CHOP-caspase-11 pathway. Am. J. Physiol. Renal Physiol., 306, F75-F84 (2014).
4. Kelly KJ, Sutton TA, Weathered N, Ray N, Caldwell EJ, Plotkin Z, Dagher PC. Minocycline inhibits apoptosis and infammation in a rat model of ischemic renal injury. Am. J. Physiol. Renal Physiol., 287, F760-F766 (2004).
5. Jin X, Chen J, Hu Z, Chan L, Wang Y. Genetic deficiency of adiponectin protects against acute kidney injury. Kidney Int., 83, 604-614 (2013).
6. Havasi A, Borkan SC. Apoptosis and acute kidney injury. Kidney Int., 80, 29-40 (2011).
7. Kurokawa M, Kornbluth S. Caspases and kinases in a death grip. Cell, 138, 838-854 (2009).
8. Jamnicki-Abegg M, Weihrauch D, Pagel PS, Kersten JR, Bosnjak ZJ, Warltier DC, Bienengraeber MW. Isofurane inhibits cardiac myocyte apoptosis during oxidative and infammatory stress by activating Akt and enhancing Bcl-2 expression. Anesthesiology, 103, 1006-1014 (2005).
9. Schmidt R, Tritschler E, Hoetzel A, Loop T, Humar M, Halverscheid L, Geiger KK, Pannen BH. Heme oxygenase-1 induction by the clinically used anesthetic isofurane protects rat livers from ischemia/reperfusion injury. Ann. Surg., 245, 931-942 (2007).
10. Zhou Y, Lekic T, Fathali N, Ostrowski RP, Martin RD, Tang J, Zhang JH. Isofurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1-phosphate/phosphatidylinositol-3-kinase/Akt pathway. Stroke, 41, 1521-1527 (2010).
11. Zhang L, Huang H, Cheng J, Liu J, Zhao HL, Vizcaychipi MP, Ma DQ. Pre-treatment with isofurane ameliorates renal ischemicreperfusion injury in mice. Life Sci., 88, 1102-1107 (2011).
12. Hashiguchi H, Morooka H, Miyoshi H, Matsumoto M, Koji T, Sumikawa K. Isofurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK. Anesth. Analg., 101, 1584-1589 (2005).
13. Li ZQ, Rong XY, Liu YJ, Ni C, Tian XS, Mo N, Chui DH, Guo XY. Activation of the canonical nuclear factor-kappaB pathway is involved in isofurane-induced hippocampal interleukin-1beta elevation and the resultant cognitive deficits in aged rats. Biochem. Biophys. Res. Commun., 438, 628-634 (2013).
14. Liu Y, Ni C, Tang Y, Tian X, Zhou Y, Qian M, Li ZQ, Chui D, Guo X. Melatonin attenuates isofurane-induced acute memory impairments in aged rats. Basic Clin. Pharmacol. Toxicol., 113, 215-220 (2013).
15. Lee HT, Kim M, Kim M, Kim N, Billings FT 4th, D'Agati VD, Emala CW Sr. Isofurane protects against renal ischemia and reperfusion injury and modulates leukocyte infiltration in mice. Am. J. Physiol. Renal Physiol., 293, F713-F722 (2007).
16. Jablonski P, Howden BO, Rae DA, Birrell CS, Marshall VC, Tange J. An experimental model for assessment of renal recovery from warm ischemia. Transplantation, 35, 198-204 (1983).
17. Molitoris BA, Dagher PC, Sandoval RM, Campos SB, Ashush H, Fridman E, Brafman A, Faerman A, Atkinson SJ, Thompson JD, Kalinski H, Skaliter R, Erlich S, Feinstein E. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J. Am. Soc. Nephrol., 20, 1754-1764 (2009).
18. Gui D, Guo Y, Wang F, Liu W, Chen J, Chen Y, Huang J, Wang N. Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo. PLoS ONE, 7, e39824 (2012).
19. Kim M, Kim M, Kim N, D'Agati VD, Emala CW Sr, Lee HT. Isofurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways. Am. J. Physiol. Renal Physiol., 293, F1827-F1835 (2007).
20. Wan X, Fan L, Hu B, Yang J, Li X, Chen X, Cao CC. Small interfering RNA targeting IKKbeta prevents renal ischemia-reperfusion injury in rats. Am. J. Physiol. Renal Physiol., 300, F857-F863 (2011).
21. Bianchi ME, Beltrame M, Paonessa G. Specific recognition of cruciform DNA by nuclear protein HMG1. Science, 243, 1056-1059 (1989).
22. Yang H, Wang H, Czura CJ, Tracey KJ. The cytokine activity of H MGB1. J. Leukoc. Biol., 78, 1-8 (2005).
23. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers infammation. Nature, 418, 191-195 (2002).
24. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest., 117, 2847-2859 (2007).
25. Wu H, Steenstra R, de Boer EC, Zhao CY, Ma J, van der Stelt JM, Chadban SJ. Preconditioning with recombinant high-mobility group box 1 protein protects the kidney against ischemia-reperfusion injury in mice. Kidney Int., 85, 824-832 (2014).
26. Wu H, Ma J, Wang P, Corpuz TM, Panchapakesan U, Wyburn KR, Chadban SJ. HMGB1 contributes to kidney ischemia reperfusion injury. J. Am. Soc. Nephrol., 21, 1878-1890 (2010).
27. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 18, 6853-6866 (1999).
28. Yang Y, Wang J, Yang Q, Wu SS, Yang ZG, Zhu HH, Zheng M, Liu WX, Wu W, He JL, Chen Z. Shikonin inhibits the lipopolysaccharide-induced release of HMGB1 in RAW264.7 cells via IFN and NF-kappaB signaling pathways. Int. Immunopharmacol., 19, 81-87 (2014).
29. Mudaliar H, Pollock C, Komala MG, Chadban S, Wu H, Panchapakesan U. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating infammation in proximal tubules. Am. J. Physiol. Renal Physiol., 305, F143-F154 (2013).
30. Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis-the p53 network. J. Cell Sci., 116, 4077-4085 (2003).
31. Zhao ZQ, Nakamura M, Wang NP, Velez DA, Hewan-Lowe KO, Guyton RA, Vinten-Johansen J. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion. J. Surg. Res., 94, 133-144 (2000).
32. Zhao ZQ, Budde JM, Morris C, Wang NP, Velez DA, Muraki S, Guyton RA, Vinten-Johansen J. Adenosine attenuates reperfusioninduced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins. J. Mol. Cell. Cardiol., 33, 57-68 (2001).